Search results
Added:
3 years ago
Heart rate variability (HRV) is considered to be a means of assessing autonomic function. However, HRV alone provides mixed measures of autonomic function1–11 and, as a result, cannot provide much insight into the autonomic involvement in arrhythmia.1,6,10 When HRV analysis is employed in conjunction with respiratory activity (RA) analysis, it has been shown to independently, simultaneously, and…
View more
Added:
3 years ago
Since its introduction in 1987, the Maze procedure has been regarded as the 'gold standardÔÇÖ for the surgical treatment of atrial fibrillation (AF). However, the complexity of the procedure has restricted its adoptability in the surgical community and provided an impetus for the development of less complex operations for the effective treatment of AF. As Dr James Cox has noted, the absolute…
View more
Added:
6 years ago
Matthew Reynolds from Lahey Hospital & Medical Center, Burlington, Massachusetts, USA discusses AEIOU: Apixaban Evaluation of Interrupted or Uninterrupted Anticoagulation for Ablation of Atrial Fibrillation.
Filmed by Radcliffe Cardiology on-site at HRS 2017.
View more
Added:
1 year ago
AHA 22 - Dr Jonathan Piccini(Duke University Medical Center, Durham, US) joins us to discuss the findings of the NOVA Phase II trial (NCT03779841).
NOVA Phase II is a multicenter, randomized, dose-ranging study that aims to find the efficacy and safety of botulinum toxin type A (AGN-151607) (AbbVie)in preventing post-operative atrial fibrillation (POAF) in patients undergoing open-chest cardiac…
View more
Added:
1 year ago
ACC.23/WCC - Principal Investigator, DrAtul Verma (McGill University Health Centre, CA) joins us on-site at ACC's 2023 Scientific Sessions to outline the findings of the PULSED-AF Trial(Medtronic Cardiac Rhythm and Heart Failure) (NCT04198701).
In this prospective, multicenter study, 421 patients with persistent atrial fibrillation (AF) were treated with the Medtronic PulseSelect Pulsed Field…
View more
Added:
1 year ago
AHA 22: Dr Paul Wang (Cardiac Arrhythmia Service at Palo Alto, Stanford, CA, US) joins us remotely to discuss the findings of the ENHANCE-AF trial, originally presented at the American Heart Association's 2022 Scientific Sessions.
ENHANCE AF aimed to evaluate whether a shared-decision-making pathway tool would reduce the risk of stroke as a result of atrial fibrillation when compared to standard…
View more
Added:
3 years ago
Atrial fibrillation (AF) is the most common cardiac arrhythmia, becomes more prevalent with age,1 and is associated with an increased long-term risk for stroke, heart failure, and all-cause mortality.2 AF can occur in the absence of underlying heart disease, but is more frequent in connection with mitral valve disease, heart failure, ischemic heart disease, and hypertension.3
Over the past…
View more
Added:
3 years ago
Atrial fibrillation (AF) is the most commonly sustained cardiac arrhythmia observed in clinical practice with a prevalence of over 2,200,000 adults in the US. The prevalence of AF increases with age, from <1% among persons <60 years of age, to approximately 10% among those aged ÔëÑ80 years. AF is associated with an increased long-term risk of stroke, heart failure, and all-cause mortality…
View more
Added:
3 years ago
Atrial fibrillation (AF) is the most commonly sustained cardiac arrhythmia observed in clinical practice with a prevalence of over 2,200,000 adults in the US.1 The prevalence of AF increases with age, from <1% among persons <60 years of age, to approximately 10% among those aged ÔëÑ80 years.2 AF is associated with an increased long-term risk of stroke, heart failure, and all-cause mortality…
View more
Added:
1 year ago
TCT 2022 - Dr Dhanunjaya Lakkireddy (University of Kansas Hospital, Kansas City, US) joins us to discuss the safety and efficacy of the Amulet Left Atrial Appendage Occluder as suggested by the results of the AMULET-IDE Study.
AMULET-IDE was a prospective, multi-center study with a cohort of 1878 patients with non-valvular atrial fibrillation. Participants were randomized to receive either the…
View more
« First